Skip to content

Gross Profit at other companies

Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$20.99M+1,604%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$125.25M+62.5%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$19.43M+154%
AbbVie logo
AbbVieABBV
$10.78B+15.4%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$34.32M+80.1%
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$3.0B+7.8%
Operating income$1.1B+80.6%
Net income$1.0B+59.6%
EPS (diluted)$4.02+61.4%

Balance sheet

See full
Cash & equivalents$5.5B+17.5%
Total debt$2.0B+20.5%
Total equity$19.4B+17.4%
Total assets$26.5B+15.8%

Cash flow

See full
Operating cash flow$1.4B+74.4%
CapEx$133.4M+228%
Free cash flow$1.3B+66.4%

Valuation

See full
Market cap$121.87B+7.6%
Enterprise value$118.35B+7.4%
P/E28.1×
P/S10×-0.2×

Profitability

See full
Gross margin86.2%+0.2pp
Operating margin38.3%
Net margin35.5%
FCF margin30.4%+20.2pp

Returns & leverage

See full
Return on equity24.2%
Debt / equity0.1×0.0×
Current ratio+0.4×

Where this comes from

Calculated from Vertex Pharmaceuticals’s reported figures.

The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vertex Pharmaceuticals's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vertex Pharmaceuticals's gross profit?
Vertex Pharmaceuticals (VRTX) reported gross profit of $2.59B in Q1 2026.
How has Vertex Pharmaceuticals's gross profit changed year-over-year?
Vertex Pharmaceuticals's gross profit increased by 7.8% year-over-year, from $2.41B to $2.59B.
What is the long-term trend for Vertex Pharmaceuticals's gross profit?
Over 4 years (2021 to 2025), Vertex Pharmaceuticals's gross profit has grown at a 11.6% compound annual growth rate (CAGR), from $6.67B to $10.35B.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.